EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma

Jialei Weng, Shaoqing Liu, Qiang Zhou, Wenxin Xu, Minghao Xu, Dongmei Gao, Yinghao Shen, Yong Yi, Yi Shi, Qiongzhu Dong, Chenhao Zhou iD, Ning Ren iD

Journal for ImmunoTherapy of Cancer · 2023

DOI: 10.1136/jitc-2022-006655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2023. Verfasst von Jialei Weng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and C…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project, Special Foundation for Science and Technology Basic Research Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a malignancy with limited treatment options and poor prognosis. Macrophages are enriched in the HCC microenvironment and have a significant impact on disease progression and therapy efficacy. We aim to identify critical macrophages subsets involved in HCC development.

Methods

Macrophage-specific marker genes were identified through single-cell RNA sequencing analyses. The clinical significance of macrophages with palmitoyl-protein thioesterase 1 (PPT1) positive was investigated in 169 patients with HCC from Zhongshan Hospital using immunohistochemistry and immunofluorescence. The immune microenvironment of HCC and the functional phenotype of PPT1 + macrophages were explored using cytometry by time-of-flight (CyTOF) and RNA sequencing.

Results

Single-cell RNA sequencing analyses revealed that PPT1 was predominantly expressed in macrophages in HCC. Intratumoral PPT1 + macrophages abundance was associated with inferior survival durations of patients and an independent risk factor of prognosis for HCC. High throughput analyses of immune infiltrates showed that PPT1 + macrophage-enriched HCCs were characterized by high infiltration of CD8 + T cells with increased programmed death-1 (PD-1) expression. PPT1 + macrophages exhibited higher galectin-9, CD172a, and CCR2 levels but lower CD80 and CCR7 levels than PPT1 − macrophages. Pharmacological inhibition of PPT1 by DC661 suppressed mitogen-activated protein kinase (MAPK) pathway activity but activated nuclear factor kappa B (NF-κB) pathway in macrophages. In addition, DC661 enhanced the therapeutic efficacy of anti-PD-1 antibody in the HCC mouse model.

Conclusions

PPT1 is mainly expressed in macrophages in HCC and promotes immunosuppressive transformation of macrophages and tumor microenvironment. PPT1 + macrophage infiltration is associated with poor prognosis of patients with HCC. Targeting PPT1 may potentiate the efficacy of immunotherapy for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAnimalsMiceCD8-Positive T-LymphocytesImmunotherapyImmunosuppressive AgentsTumor MicroenvironmentThiolester Hydrolases

Stichwörter der Autor:innen

ImmunotherapyLiver NeoplasmsMacrophagesTumor BiomarkersTumor Microenvironment

Substanzen

Immunosuppressive Agentspalmitoyl-protein thioesteraseThiolester Hydrolases

Autor:innen und Institutionen

  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China.
  • Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer of Shanghai Municipal Health Commission, Shanghai, China.
  • Biomedical Research Centre, Zhongshan Hospital Fudan University, Shanghai, China.
  • Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.
  • Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai, China ren.ning@zs-hos…

ORCID-Profile: Chenhao Zhou, Ning Ren

Förderung

  • Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project
  • Special Foundation for Science and Technology Basic Research Program
  • National Natural Science Foundation of China
  • Sino-German Mobility Program
  • Shanghai Sailing Program
  • China Postdoctoral Science Foundation

Zitieren

APA

Weng, J., Liu, S., Zhou, Q., Xu, W., Xu, M., Gao, D., Shen, Y., Yi, Y., Shi, Y., Dong, Q., Zhou, C., & Ren, N. (2023). Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2022-006655

Vancouver

Weng J, Liu S, Zhou Q, Xu W, Xu M, Gao D, et al. Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 2023. doi:10.1136/jitc-2022-006655

BibTeX
@article{Weng2023,
  author = {Weng, Jialei and Liu, Shaoqing and Zhou, Qiang and Xu, Wenxin and Xu, Minghao and Gao, Dongmei and Shen, Yinghao and Yi, Yong and Shi, Yi and Dong, Qiongzhu and Zhou, Chenhao and Ren, Ning},
  title = {Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  doi = {10.1136/jitc-2022-006655}
}
Kostenlos starten →